Web23 mrt. 2024 · Dr. John McCafferty was the pioneer and inventor of antibody-phage display and co-founder of Cambridge Antibody Technology, which was subsequently acquired by MedImmune. On leaving CAT, John established a highly proficient proteomics group at the Wellcome Trust Sanger Institute which developed cutting edge protein expression and … Web8 mrt. 2024 · IONTAS Limited (IONTAS) and FairJourney Biologics S.A (FJB)., leaders in the discovery and optimisation of fully human antibodies, have announced that
Beyond affinity: selection of antibody variants with optimal ...
WebIontas develops software solutions that positively impact the effectiveness and efficiency of desktop based processes. With a suite of tools providing capture, analysis and … Web9 jun. 2024 · Antibody discovery has become increasingly important in almost all areas of modern medicine. Different antibody discovery approaches exist, but one that has gained increasing interest in the field of toxinology and antivenom research is phage display technology. In this review, the lifecycle of the … port integrative therapy
John McCafferty, PhD
Webwhat\u0027s new at ces 2024. ces 2024 new products. ces 2024 new electronic. ces 2024 new tv. companies at ces 2024. latest news on televisions at ces 2024. news from ces 2024. WebThis combination creates a leading global antibody discovery CRO within our industry, offering unparalleled antibody services and technology platforms to global biopharmas , biotechs, universities, virtual companies and other innovative partnerships. Notable numbers about our network View our technologies 13 Antibodies in clinic Web25 jun. 2024 · Dr Neil Butt, CBO of IONTAS said: “This new agreement marks IONTAS’ expansion into the Asian market and we are delighted to have been selected by LG Chem, Ltd, after a rigorous diligence process. The application of our proprietary technologies will assist LG Chem Ltd in expanding its current therapeutic pipeline by generating leads … irnt sec filings